- Home
- NRIX vs ABR Comparison
NRIX vs ABR Comparison
Compare NRIX & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | ABR |
|---|---|---|
| Founded | 2009 | 2003 |
| Country | United States | United States |
| Employees | 357 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | NRIX | ABR |
|---|---|---|
| Price | $15.62 | $7.84 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 5 |
| Target Price | ★ $29.46 | $10.30 |
| AVG Volume (30 Days) | 690.4K | ★ 4.8M |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 15.04% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $76,987,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $26.32 | $4.47 |
| P/E Ratio | ★ N/A | $9.29 |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $8.18 | $7.11 |
| 52 Week High | $22.50 | $12.58 |
Technical Indicators
Market Signals| Indicator | NRIX | ABR |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 47.83 |
| Support Level | $15.62 | $7.32 |
| Resistance Level | $16.47 | $8.20 |
| Average True Range (ATR) | 0.80 | 0.33 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 57.14 | 41.06 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.